GlassScriptPhysician profile
Joseph J Tseng
NPI 1558518332
$6,192.98
in general payments reported to CMS, 2019-2025
18 companies · $342 in 2025
The $342 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,111 · 2020: $400 · 2021: $476 · 2022: $183 · 2023: $201 · 2024: $479 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $823 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $822.68 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $3,738.86 | 2019 | |
| Mallinckrodt Hospital Products INC. | $547.93 | 2020-2025 | Acthar |
| Glaukos Corporation | $276.07 | 2019-2024 | Idose |
| Johnson & Johnson Surgical Vision, INC. | $214.93 | 2023-2025 | Tecnis Iol, Catalys System, Veritas Vision System |
| Alcon Vision LLC | $172.23 | 2019-2025 | Hydrus Microstent, Eysuvis |
| Genentech USA, INC. | $158.49 | 2019-2024 | Vabysmo |
| Alimera Sciences, INC. | $150.07 | 2021 | |
| Dompe US, INC. | $148.81 | 2020 | |
| Novartis Pharmaceuticals Corporation | $147.05 | 2021 | |
| Eyepoint US, INC. | $140.95 | 2020-2021 | |
| Abbvie INC. | $98.28 | 2023-2024 | Lumigan |
| Rxsight INC | $97.91 | 2024 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Astellas Pharma US INC | $85.54 | 2025 | Izervay |
| Regeneron Healthcare Solutions, INC. | $84.09 | 2019-2025 | Eylea Hd |
| Bausch & Lomb Americas INC. | $52.02 | 2022-2024 | Xipere |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $45.18 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $15.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Tseng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.